Meridian Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.2M Sell
76,766
-1,053
-1% -$195K 0.61% 29
2025
Q1
$16.3M Buy
77,819
+5,530
+8% +$1.16M 0.79% 18
2024
Q4
$12.8M Sell
72,289
-2,589
-3% -$460K 0.61% 31
2024
Q3
$14.8M Buy
74,878
+2,363
+3% +$467K 0.73% 24
2024
Q2
$12.4M Buy
+72,515
New +$12.4M 1.49% 12
2024
Q1
Sell
-71,481
Closed -$11.1M 200
2023
Q4
$11.1M Buy
71,481
+24,996
+54% +$3.87M 0.71% 25
2023
Q3
$6.93M Buy
46,485
+3,439
+8% +$513K 0.42% 48
2023
Q2
$5.8M Sell
43,046
-51
-0.1% -$6.87K 0.49% 31
2023
Q1
$6.87M Buy
43,097
+5,041
+13% +$803K 0.6% 28
2022
Q4
$6.15M Sell
38,056
-1,072
-3% -$173K 0.6% 25
2022
Q3
$5.25M Sell
39,128
-1,806
-4% -$242K 0.56% 28
2022
Q2
$6.27M Sell
40,934
-3,214
-7% -$492K 0.51% 41
2022
Q1
$7.16M Sell
44,148
-2,723
-6% -$441K 0.78% 22
2021
Q4
$6.35M Buy
46,871
+2,069
+5% +$280K 0.68% 26
2021
Q3
$4.83M Buy
44,802
+4,751
+12% +$513K 0.6% 30
2021
Q2
$4.51M Buy
40,051
+5,099
+15% +$574K 0.57% 35
2021
Q1
$3.78M Sell
34,952
-5,377
-13% -$582K 0.55% 37
2020
Q4
$4.32M Buy
40,329
+2,635
+7% +$282K 0.69% 28
2020
Q3
$3.3M Buy
37,694
+11,699
+45% +$1.02M 0.81% 22
2020
Q2
$2.55M Buy
25,995
+586
+2% +$57.5K 0.85% 21
2020
Q1
$1.94M Buy
25,409
+21,406
+535% +$1.63M 0.86% 24
2019
Q4
$354K Buy
4,003
+169
+4% +$14.9K 0.17% 133
2019
Q3
$290K Buy
3,834
+596
+18% +$45.1K 0.14% 154
2019
Q2
$2.36K Buy
3,238
+68
+2% +$49 0.1% 180
2019
Q1
$255K Buy
3,170
+221
+7% +$17.8K 0.12% 158
2018
Q4
$272K Buy
2,949
+805
+38% +$74.2K 0.16% 125
2018
Q3
$203K Sell
2,144
-3,663
-63% -$347K 0.09% 161
2018
Q2
$538K Buy
5,807
+3,273
+129% +$303K 0.25% 78
2018
Q1
$240K Sell
2,534
-354
-12% -$33.5K 0.12% 155
2017
Q4
$279K Buy
2,888
+35
+1% +$3.38K 0.17% 132
2017
Q3
$257K Sell
2,853
-4,391
-61% -$396K 0.16% 136
2017
Q2
$525K Buy
7,244
+4,114
+131% +$298K 0.33% 74
2017
Q1
$204K Buy
+3,130
New +$204K 0.12% 159